Anthea WirgesCo-founder and CEO at CARTemis Therapeutics GmbHSpeaker
Profile
Anthea Wirges, co-founder and CEO of CARTemis Therapeutics GmbH, has more than 10 years of scientific experience in generating CAR T-cells for immunotherapy of cancer. Helmholtz Enterprise and the EIC Women Leadership Programme supported her transition to entrepreneurship. Very recently, she belongs to the winners of the first Women TechEU call.